Medications

Repurposed drug could help patients with motor neuron disease

A drug typically used to treat enlarged prostates and high blood pressure has shown promise as a potential new therapy for motor neuron disease (MND)—also known as amyotrophic lateral sclerosis (ALS)—according to a new ...

Neuroscience

Gaining insights into spastic paraplegia

Rare diseases, as the name indicates, only affect a small part of the population. However, for those affected they are particularly challenging, often especially because research into such rare diseases tends to be less of ...

Neuroscience

Ketamine found to be unlikely to lead to addiction

A team of researchers at the University of Geneva has found that ketamine is unlikely to be addictive to people who use it for extended periods of time. In their paper published in the journal Nature, the group describes ...

Medical research

ALS: Early disease mechanisms discovered

Currently, there is no cure for amyotrophic lateral sclerosis (ALS). Things could soon change, however. Researchers at FAU and the University of California San Diego (UCSD) have identified a protein that already displays ...

Health

Vitamin B6 supplements could reduce anxiety and depression

Scientists at the University of Reading measured the impact of high doses of Vitamin B6 on young adults and found that they reported feeling less anxious and depressed after taking the supplements every day for a month.

Parkinson's & Movement disorders

A new wearable system tracks Parkinson's disease symptoms remotely

Parkinson's disease affects 10 million people worldwide and its symptoms include tremors in the fingers and hands, small handwriting, loss of smell, walking difficulties, dizziness, and others. As these symptoms worsen over ...

page 30 from 40